ID

31015

Description

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00431210

Link

https://clinicaltrials.gov/show/NCT00431210

Keywords

Versions (1)
  1. 7/10/18 7/10/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 10, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Nasopharyngeal Carcinoma NCT00431210

English

Eligibility Nasopharyngeal Carcinoma NCT00431210

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically proven npc of any who grade, associated with ebv documented by the presence of eber by in situ hybridization in the tumor. this must be confirmed by pathology review at brigham and women's hospital.
Description

Nasopharyngeal carcinoma WHO tumor classification | Epstein-Barr Virus Associated | EBER Present In Situ Hybridization

Data type

boolean

Alias
UMLS CUI [1,1]
C2931822
UMLS CUI [1,2]
C1301142
UMLS CUI [2,1]
C0014644
UMLS CUI [2,2]
C0332281
UMLS CUI [3,1]
C3830308
UMLS CUI [3,2]
C0150312
UMLS CUI [3,3]
C0162788
incurable npc as defined by: relapsed or progressive disease after initial treatment with no potentially curative option; npc with metastasis
Description

Nasopharyngeal carcinoma incurable | Recurrent disease | Progressive Disease | Therapeutic procedure Initial | Curative treatment Lacking | Metastatic malignant neoplasm to nasopharynx

Data type

boolean

Alias
UMLS CUI [1,1]
C2931822
UMLS CUI [1,2]
C0175969
UMLS CUI [2]
C0277556
UMLS CUI [3]
C1335499
UMLS CUI [4,1]
C0087111
UMLS CUI [4,2]
C0205265
UMLS CUI [5,1]
C1273390
UMLS CUI [5,2]
C0332268
UMLS CUI [6]
C1334731
recovery from toxicity from any prior npc therapy to grade 1 or better (ctcace v.3.0)
Description

Toxicity Due to Prior Therapy Nasopharyngeal carcinoma | Toxicity CTCAE Grades | Patient recovered

Data type

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C1514463
UMLS CUI [1,4]
C2931822
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C1516728
UMLS CUI [3]
C1115804
18 years of age or older
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
evaluable disease, according to recist
Description

Evaluable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1516986
ecog performance status of 0-1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow, liver and renal function
Description

Bone Marrow function | Liver function | Renal function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
radiotherapy for primary npc within 8 weeks of enrollment, or radiotherapy for any other reason within 6 weeks
Description

Therapeutic radiology procedure Nasopharyngeal carcinoma Primary | Therapeutic radiology procedure Reason Any

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C2931822
UMLS CUI [1,3]
C0205225
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0392360
UMLS CUI [2,3]
C1552551
chemotherapy for npc within 2 weeks of enrollment
Description

Chemotherapy Nasopharyngeal carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C2931822
other cancer in the past 5 years, except for carcinoma in situ of the cervix or bladder, or non-melanomatous skin cancer
Description

Cancer Other | Exception Carcinoma in situ of uterine cervix | Exception Carcinoma in situ of bladder | Exception Skin carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0851140
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0154091
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0699893
uncontrolled central nervous system metastases
Description

CNS metastases Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0205318
acute hepatitis, known hiv, or other condition that requires immunosuppressive therapy, including current use of systemic corticosteroids
Description

Hepatitis | HIV Infections | Condition Requirement Therapeutic immunosuppression | CORTICOSTEROIDS FOR SYSTEMIC USE

Data type

boolean

Alias
UMLS CUI [1]
C0019158
UMLS CUI [2]
C0019693
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C1514873
UMLS CUI [3,3]
C0021079
UMLS CUI [4]
C3653708
autoimmune disease that is active and requires current therapy
Description

Autoimmune Disease Treatment required for

Data type

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0332121
active, uncontrolled, serious infection
Description

Communicable Disease Serious Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0205318
incomplete healing from previous major surgery
Description

Healing Incomplete | Etiology Major surgery Previous

Data type

boolean

Alias
UMLS CUI [1,1]
C0043240
UMLS CUI [1,2]
C0205257
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0679637
UMLS CUI [2,3]
C0205156
significant history of uncontrolled cardiac disease
Description

Heart Disease Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205318
women who have a positive b-hcg test or are breastfeeding
Description

Serum pregnancy test (B-HCG) Positive | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1,1]
C0430060
UMLS CUI [1,2]
C1514241
UMLS CUI [2]
C0006147
any concurrent chemotherapy or other concurrent investigational agent not part of this study
Description

Chemotherapy Except for Study Protocol | Investigational New Drugs Except for Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C2348563
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0332300
UMLS CUI [2,3]
C2348563
Back to the top of the page

Similar models

Eligibility Nasopharyngeal Carcinoma NCT00431210

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Nasopharyngeal carcinoma WHO tumor classification | Epstein-Barr Virus Associated | EBER Present In Situ Hybridization
Item
histologically or cytologically proven npc of any who grade, associated with ebv documented by the presence of eber by in situ hybridization in the tumor. this must be confirmed by pathology review at brigham and women's hospital.
boolean
C2931822 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C0014644 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C3830308 (UMLS CUI [3,1])
C0150312 (UMLS CUI [3,2])
C0162788 (UMLS CUI [3,3])
Nasopharyngeal carcinoma incurable | Recurrent disease | Progressive Disease | Therapeutic procedure Initial | Curative treatment Lacking | Metastatic malignant neoplasm to nasopharynx
Item
incurable npc as defined by: relapsed or progressive disease after initial treatment with no potentially curative option; npc with metastasis
boolean
C2931822 (UMLS CUI [1,1])
C0175969 (UMLS CUI [1,2])
C0277556 (UMLS CUI [2])
C1335499 (UMLS CUI [3])
C0087111 (UMLS CUI [4,1])
C0205265 (UMLS CUI [4,2])
C1273390 (UMLS CUI [5,1])
C0332268 (UMLS CUI [5,2])
C1334731 (UMLS CUI [6])
Toxicity Due to Prior Therapy Nasopharyngeal carcinoma | Toxicity CTCAE Grades | Patient recovered
Item
recovery from toxicity from any prior npc therapy to grade 1 or better (ctcace v.3.0)
boolean
C0600688 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C2931822 (UMLS CUI [1,4])
C0600688 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
C1115804 (UMLS CUI [3])
Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
Evaluable Disease
Item
evaluable disease, according to recist
boolean
C1516986 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0-1
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver and renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure Nasopharyngeal carcinoma Primary | Therapeutic radiology procedure Reason Any
Item
radiotherapy for primary npc within 8 weeks of enrollment, or radiotherapy for any other reason within 6 weeks
boolean
C1522449 (UMLS CUI [1,1])
C2931822 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0392360 (UMLS CUI [2,2])
C1552551 (UMLS CUI [2,3])
Chemotherapy Nasopharyngeal carcinoma
Item
chemotherapy for npc within 2 weeks of enrollment
boolean
C0392920 (UMLS CUI [1,1])
C2931822 (UMLS CUI [1,2])
Cancer Other | Exception Carcinoma in situ of uterine cervix | Exception Carcinoma in situ of bladder | Exception Skin carcinoma
Item
other cancer in the past 5 years, except for carcinoma in situ of the cervix or bladder, or non-melanomatous skin cancer
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0154091 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0699893 (UMLS CUI [4,2])
CNS metastases Uncontrolled
Item
uncontrolled central nervous system metastases
boolean
C0686377 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Hepatitis | HIV Infections | Condition Requirement Therapeutic immunosuppression | CORTICOSTEROIDS FOR SYSTEMIC USE
Item
acute hepatitis, known hiv, or other condition that requires immunosuppressive therapy, including current use of systemic corticosteroids
boolean
C0019158 (UMLS CUI [1])
C0019693 (UMLS CUI [2])
C0348080 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0021079 (UMLS CUI [3,3])
C3653708 (UMLS CUI [4])
Autoimmune Disease Treatment required for
Item
autoimmune disease that is active and requires current therapy
boolean
C0004364 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
Communicable Disease Serious Uncontrolled
Item
active, uncontrolled, serious infection
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Healing Incomplete | Etiology Major surgery Previous
Item
incomplete healing from previous major surgery
boolean
C0043240 (UMLS CUI [1,1])
C0205257 (UMLS CUI [1,2])
C0015127 (UMLS CUI [2,1])
C0679637 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
Heart Disease Uncontrolled
Item
significant history of uncontrolled cardiac disease
boolean
C0018799 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Serum pregnancy test (B-HCG) Positive | Breast Feeding
Item
women who have a positive b-hcg test or are breastfeeding
boolean
C0430060 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
Chemotherapy Except for Study Protocol | Investigational New Drugs Except for Study Protocol
Item
any concurrent chemotherapy or other concurrent investigational agent not part of this study
boolean
C0392920 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0013230 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C2348563 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial